
    
      The objective of this study is to evaluate the relationship between Coronavirus Disease 2019
      (COVID-19) in pregnancy and adverse perinatal outcomes. The secondary aim is to analyze the
      diagnostic value of hematologic parameters in COVID-19 complicated pregnancies.The current
      study is conducted in a high volume tertiary obstetrics center burdened by COVID-19
      pandemics, in Turkey, between March 20 and July 25, 2020. The study included a pregnant women
      cohort who had been regularly followed up and delivered in our clinics. The cohort was
      divided into two groups to reveal the impact of COVID-19 on the complete blood count cell
      indices and unfavorable obstetric and early neonatal outcomes in pregnant women. The
      clinically confirmed diagnosis of COVID-19 cases were included in Study Group (n=39) the
      healthy pregnant women without COVID-19 were included in Control Group (n=69). The study
      achieved a power of 0.89 and 0.98 with a 5% level of significance.
    
  